XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 71 filers reported holding XENON PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $4,497,000 | -67.5% | 396,589 | -71.8% | 0.41% | -68.7% |
Q2 2019 | $13,858,000 | -3.0% | 1,405,476 | 0.0% | 1.30% | -8.8% |
Q1 2019 | $14,280,000 | +61.0% | 1,405,476 | 0.0% | 1.42% | +25.7% |
Q4 2018 | $8,869,000 | -52.2% | 1,405,476 | 0.0% | 1.13% | -39.4% |
Q3 2018 | $18,552,000 | – | 1,405,476 | – | 1.87% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 2,754,266 | $107,388,831 | 7.33% |
Altium Capital Management LP | 360,600 | $14,059,794 | 5.74% |
Affinity Asset Advisors, LLC | 994,227 | $38,764,911 | 4.47% |
First Light Asset Management, LLC | 1,306,260 | $50,931,077 | 4.46% |
Nan Fung Group Holdings Ltd | 106,680 | $4,159,453 | 4.44% |
Ally Bridge Group (NY) LLC | 169,369 | $6,603,697 | 3.93% |
TLS Advisors LLC | 32,956 | $1,285 | 3.22% |
BRAIDWELL LP | 2,560,573 | $99,836,741 | 3.13% |
Paradigm Biocapital Advisors LP | 2,043,280 | $79,667,487 | 3.05% |
BRIDGER MANAGEMENT, LLC | 146,800 | $5,723,732 | 2.94% |